SEARCH RESULTS FOR: !$최신효율적인주식DB문의처☑️!텔DBchance(525 results)

Export results
Filters
Sort By
10
Results Per Page
10
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Lixelle - 14993478020225

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-25
Not in Commercial Distribution

  • 24993478020222 ()
  • 14993478020225 ()
  • 04993478010069 ()
N/A

  • Haemoperfusion system absorption column

Lixelle - 14993478020218

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-15
Not in Commercial Distribution

  • 14993478020218 ()
  • 04993478010052 ()
  • 24993478020215 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010066

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-25
In Commercial Distribution

  • 04993478010069 ()
  • 14993478010066 ()
  • 24993478010063 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010059

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-15
In Commercial Distribution

  • 04993478010052 ()
  • 14993478010059 ()
  • 24993478010056 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010042

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-35
In Commercial Distribution

  • 24993478010049 ()
  • 14993478010042 ()
  • 04993478010045 ()
N/A

  • Haemoperfusion system absorption column

EDWARDS SAPIEN 3 PULMONIC DELIVERY SYSTEM (29MM) - 00690103210873

SAPIEN 3 PULMONIC DELIVERY SYSTEM - 29MM (US)
Edwards Lifesciences LLC
9630PL29A
In Commercial Distribution

  • 00690103210873 ()

  • Balloon Diameter: 29.0000 Millimeter
9630PL29A

  • Pulmonary transcatheter heart valve bioprosthesis

THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM - 00690103210866

ALTERRA ADAPTIVE PRESTENT SYSTEM (US) 40MM X 48MM
Edwards Lifesciences LLC
29AP4045
In Commercial Distribution

  • 00690103210866 ()
29AP4045A

  • Pulmonary transcatheter heart valve bioprosthesis

CERENOVUS ENTERPRISE - 10886704044048

CERENOVUS ENTERPRISE Vascular Reconstruction Device and Delivery System Unconstrained Stent OD 4.5mm Unconstrained Stent Length 37mm. 12mm Distal tip. Maximum Stent foreshortening 4.7mm, Recommended Microcatheter .021inch(0.533mm)
Medos International Sàrl
ENF453712
Not in Commercial Distribution

  • 10886704044048 ()
ENF453712

  • Bare-metal intracranial vascular stent

CERENOVUS ENTERPRISE - 10886704044031

CERENOVUS ENTERPRISE Vascular Reconstruction Device and Delivery System Unconstrained Stent OD 4.5mm Unconstrained Stent Length 28mm. 12mm Distal tip. Maximum Stent foreshortening 3.2mm, Recommended Microcatheter .021inch(0.533mm)
Medos International Sàrl
ENF452812
Not in Commercial Distribution

  • 10886704044031 ()
ENF452812

  • Bare-metal intracranial vascular stent

CERENOVUS ENTERPRISE - 10886704044024

CERENOVUS ENTERPRISE Vascular Reconstruction Device and Delivery System Unconstrained Stent OD 4.5mm Unconstrained Stent Length 22mm. 12mm Distal tip. Maximum Stent foreshortening 1.9mm, Recommended Microcatheter .021inch(0.533mm)
Medos International Sàrl
ENF452212
Not in Commercial Distribution

  • 10886704044024 ()
ENF452212

  • Bare-metal intracranial vascular stent
< 1 ... 19 20 21 22 23 ... 53 >